151 related articles for article (PubMed ID: 28133909)
1. Anti-HCV for porphyria cutanea tarda.
Abdelmaksoud A
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133909
[No Abstract] [Full Text] [Related]
2. Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.
Takata K; Shakado S; Sakamoto K; Fukuda H; Yamauchi R; Fukuda S; Kunimoto H; Umeda K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Sakisaka S
Clin J Gastroenterol; 2017 Oct; 10(5):459-463. PubMed ID: 28884440
[TBL] [Abstract][Full Text] [Related]
3. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
[No Abstract] [Full Text] [Related]
4. Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
Tong Y; Song YK; Tyring S
JAMA Dermatol; 2016 Dec; 152(12):1393-1395. PubMed ID: 27732687
[No Abstract] [Full Text] [Related]
5. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
[No Abstract] [Full Text] [Related]
6. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Graf Einsiedel H; Christiansen H; Wiegand J
Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
[No Abstract] [Full Text] [Related]
7. Assessing a broader user base for new HCV drug.
Sekkides O
Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
[No Abstract] [Full Text] [Related]
8. Therapy for hepatitis C--the costs of success.
Hoofnagle JH; Sherker AH
N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
[No Abstract] [Full Text] [Related]
9. Cure with ledipasvir/sofosbuvir for chronic hepatitis C virus in an individual with gastric bypass.
Johnson SW; Teachey AL; Valanejad SM; Griffin SM; Weber SF
J Clin Pharm Ther; 2017 Oct; 42(5):624-626. PubMed ID: 28474386
[TBL] [Abstract][Full Text] [Related]
10. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).
Bourlière M; Bronowicki JP; de Ledinghen V; Hézode C; Zoulim F; Mathurin P; Tran A; Larrey DG; Ratziu V; Alric L; Hyland RH; Jiang D; Doehle B; Pang PS; Symonds WT; Subramanian GM; McHutchison JG; Marcellin P; Habersetzer F; Guyader D; Grangé JD; Loustaud-Ratti V; Serfaty L; Metivier S; Leroy V; Abergel A; Pol S
Lancet Infect Dis; 2015 Apr; 15(4):397-404. PubMed ID: 25773757
[TBL] [Abstract][Full Text] [Related]
11. Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.
Sawinski D; Lee DH; Doyle AM; Blumberg EA
Transplantation; 2017 May; 101(5):974-979. PubMed ID: 27467534
[TBL] [Abstract][Full Text] [Related]
12. Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.
Bonkovsky HL; Rudnick SP; Ma CD; Overbey JR; Wang K; Faust D; Hallberg C; Hedstrom K; Naik H; Moghe A; Anderson KE
Dig Dis Sci; 2023 Jun; 68(6):2738-2746. PubMed ID: 36811718
[TBL] [Abstract][Full Text] [Related]
13. Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment.
Gentile I; Borgia G
Evid Based Med; 2014 Dec; 19(6):223-4. PubMed ID: 25028605
[No Abstract] [Full Text] [Related]
14. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
Manns M; Samuel D; Gane EJ; Mutimer D; McCaughan G; Buti M; Prieto M; Calleja JL; Peck-Radosavljevic M; Müllhaupt B; Agarwal K; Angus P; Yoshida EM; Colombo M; Rizzetto M; Dvory-Sobol H; Denning J; Arterburn S; Pang PS; Brainard D; McHutchison JG; Dufour JF; Van Vlierberghe H; van Hoek B; Forns X;
Lancet Infect Dis; 2016 Jun; 16(6):685-697. PubMed ID: 26907736
[TBL] [Abstract][Full Text] [Related]
15. Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection.
Fouad HM; Sabry MA; Ahmed A; Hassany M; Al Soda MF; Abdel Aziz H
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):386-389. PubMed ID: 31310312
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient.
Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G
J Clin Pharm Ther; 2017 Oct; 42(5):621-623. PubMed ID: 28474408
[TBL] [Abstract][Full Text] [Related]
17. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
Afdhal N; Zeuzem S; Kwo P; Chojkier M; Gitlin N; Puoti M; Romero-Gomez M; Zarski JP; Agarwal K; Buggisch P; Foster GR; Bräu N; Buti M; Jacobson IM; Subramanian GM; Ding X; Mo H; Yang JC; Pang PS; Symonds WT; McHutchison JG; Muir AJ; Mangia A; Marcellin P;
N Engl J Med; 2014 May; 370(20):1889-98. PubMed ID: 24725239
[TBL] [Abstract][Full Text] [Related]
18. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
Charlton M; Everson GT; Flamm SL; Kumar P; Landis C; Brown RS; Fried MW; Terrault NA; O'Leary JG; Vargas HE; Kuo A; Schiff E; Sulkowski MS; Gilroy R; Watt KD; Brown K; Kwo P; Pungpapong S; Korenblat KM; Muir AJ; Teperman L; Fontana RJ; Denning J; Arterburn S; Dvory-Sobol H; Brandt-Sarif T; Pang PS; McHutchison JG; Reddy KR; Afdhal N;
Gastroenterology; 2015 Sep; 149(3):649-59. PubMed ID: 25985734
[TBL] [Abstract][Full Text] [Related]
19. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
Kowdley KV; Gordon SC; Reddy KR; Rossaro L; Bernstein DE; Lawitz E; Shiffman ML; Schiff E; Ghalib R; Ryan M; Rustgi V; Chojkier M; Herring R; Di Bisceglie AM; Pockros PJ; Subramanian GM; An D; Svarovskaia E; Hyland RH; Pang PS; Symonds WT; McHutchison JG; Muir AJ; Pound D; Fried MW;
N Engl J Med; 2014 May; 370(20):1879-88. PubMed ID: 24720702
[TBL] [Abstract][Full Text] [Related]
20. Shorter treatments for hepatitis C: another step forward?
Foster GR
Lancet; 2015 Mar; 385(9973):1054-5. PubMed ID: 25591504
[No Abstract] [Full Text] [Related]
[Next] [New Search]